Troupin A S, Shaw L M
Epilepsia. 1985 Sep-Oct;26(5):455-9. doi: 10.1111/j.1528-1157.1985.tb05680.x.
A new centrifugal membrane filtration device (Syva Corporation) has been evaluated to determine its capabilities for separation of free phenytoin for analysis. The device is a test tube-size cylinder with two compartments separated by the membrane. In serum samples from 70 patients at the Hospital of the University of Pennsylvania, free phenytoin was prepared by the new device and by equilibrium dialysis. Levels were assayed by gas chromatography and enzyme immunoassay with good agreement at all phenytoin levels. Although pH has a significant effect on the binding of some drugs to serum proteins, phenytoin binding increased to only a small extent as pH was increased from 7.0 to 7.8 (85-88.5% bound). Centrifugal filtration with this device is a reliable, fast, and easy way to prepare free drug from serum and does not include the dilution artifact inherent in equilibrium dialysis.
一种新型离心膜过滤装置(希瓦公司)已通过评估,以确定其分离游离苯妥英用于分析的能力。该装置是一个试管大小的圆柱体,有两个由膜隔开的隔室。在宾夕法尼亚大学医院70名患者的血清样本中,游离苯妥英通过这种新装置和平衡透析法制备。通过气相色谱法和酶免疫分析法测定水平,在所有苯妥英水平下结果吻合良好。虽然pH值对某些药物与血清蛋白的结合有显著影响,但当pH值从7.0增加到7.8时,苯妥英的结合仅略有增加(结合率为85 - 88.5%)。使用该装置进行离心过滤是一种从血清中制备游离药物的可靠、快速且简便的方法,且不包括平衡透析中固有的稀释假象。